Skip to content

Connection Between General Practitioner's (GP's) Estimation of Cardiovascular Risk and Theoretical Calculation in France

Connection Between GP's Estimation of Cardiovascular Risk and Theoretical Calculation in France

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01039402
Enrollment
13502
Registered
2009-12-25
Start date
2009-12-31
Completion date
2010-01-31
Last updated
2010-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Risk

Keywords

cardiovascular risk, France, Observational, descriptive study

Brief summary

The purpose of this study is to evaluate connection between GP's estimation of cardiovascular risk and theoretical calculation.

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adults 50 years old and over, visiting their GPs

Design outcomes

Primary

MeasureTime frame
To evaluate connection between GP's estimation of cardiovascular risk and theoretical calculation (according to guidelines and validated scales (such as risk score profile in the Framingham Heart study or the SCORE risk estimation))At the end of the study

Secondary

MeasureTime frame
To estimate the number of cardiovascular risk patients, that have not been identifiedAt the end of the study
To characterize those patients according to their theoretical cardiovascular risk (high, medium, low)At the end of the study
to reveal GP's estimation of cardiovascular risk is especially driven by LDLAt the end of the study

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026